An in silico viral-peptide-MHC class I binding study has since found that HLA-B*46:01 had the fewest predicted binding peptides for the closely related SARS-CoV-2, suggesting that this allele may be particularly vulnerable to COVID-19 [20]. This evidence concerns the gene HLA-B and COVID-19.